13F Data
Security · CUSIP 14875P107

CATABASIS PHARMACEUTICALS IN

COM · institutional ownership from 13F filings
13F holders
1
Shares held
285.8K
Value held
$1.2M
New / sold out
0 / 27
Added / reduced
0 / 1
net -21.0M shares

13F holders by quarter

Q2 2015: 20Q3 2015: 36Q4 2015: 34Q1 2016: 33Q2 2016: 28Q3 2016: 32Q4 2016: 26Q1 2017: 23Q2 2017: 24Q3 2017: 25Q4 2017: 25Q1 2018: 24Q2 2018: 31Q3 2018: 29Q4 2018: 1Q1 2019: 0
Q2 2015Q1 2019

Net shares bought by existing holders

Q2 2015: 10.5MQ3 2015: -163.2KQ4 2015: -89.4KQ1 2016: 238.1KQ2 2016: -263.8KQ3 2016: 1.3MQ4 2016: 173.9KQ1 2017: -4.3MQ2 2017: 21.8KQ3 2017: 252.2KQ4 2017: 654.4KQ1 2018: -328.5KQ2 2018: 21.9MQ3 2018: -6.5MQ4 2018: -21.0MQ1 2019: -285.8K
Q2 2015Q1 2019

Top holders · Q4 2018

ManagerSharesValue% of portfolio
SV Health Investors, LLC285,765$1.2M0.77%

Biggest buyers

Nothing to show.

Biggest sellers

ManagerChangeShares changeChange %
FEDERATED INVESTORS INC /PA/Sold out-10,434,000-100.0%
SV Health Investors, LLCReduced-2,571,902-90.0%
Vanguard Group IncSold out-2,494,827-100.0%
Stonepine Capital Management, LLCSold out-2,166,154-100.0%
CVI Holdings, LLCSold out-730,320-100.0%
OPPENHEIMER & CO INCSold out-508,415-100.0%
DEUTSCHE BANK AG\Sold out-505,702-100.0%
RENAISSANCE TECHNOLOGIES LLCSold out-453,740-100.0%
GEODE CAPITAL MANAGEMENT, LLCSold out-290,471-100.0%
BlackRock Inc.Sold out-170,293-100.0%
18 more rows. Subscribe for $29/month to see every row, download the data and use the API.